DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Brickwood Asset Management LLP

Brickwood Asset Management LLP grew its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 5,515.8% during the third quarter, Holdings Channel reports. The firm owned 1,524,074 shares of the medical instruments supplier’s stock after purchasing an additional 1,496,935 shares during the period. DENTSPLY SIRONA makes up approximately 14.7% of Brickwood Asset Management LLP’s investment portfolio, making the stock its 5th largest position. Brickwood Asset Management LLP’s holdings in DENTSPLY SIRONA were worth $19,340,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of XRAY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at $26,000. Parkside Financial Bank & Trust grew its holdings in shares of DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares during the last quarter. True Wealth Design LLC increased its position in shares of DENTSPLY SIRONA by 273.0% during the second quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 1,739 shares in the last quarter. Central Pacific Bank Trust Division lifted its holdings in shares of DENTSPLY SIRONA by 100.0% in the 3rd quarter. Central Pacific Bank Trust Division now owns 4,000 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 2,000 shares during the last quarter. Finally, Versant Capital Management Inc boosted its position in shares of DENTSPLY SIRONA by 878.6% in the 3rd quarter. Versant Capital Management Inc now owns 4,883 shares of the medical instruments supplier’s stock valued at $62,000 after purchasing an additional 4,384 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

More DENTSPLY SIRONA News

Here are the key news stories impacting DENTSPLY SIRONA this week:

• Positive Sentiment: Bank of America upgraded XRAY from Neutral to Buy and raised its price target to $17 from $13 (about 35.6% upside vs. the current price). The upgrade is being cited as the primary catalyst for intraday gains. B of A Securities Upgrades DENTSPLY SIRONA (XRAY) Dentsply Sirona gains as BofA upgrades to Buy on risk-reward setup
• Neutral Sentiment: The company is expected to announce quarterly earnings on Thursday, which increases near-term volatility and focus on results vs. guidance. Investors should watch the report for revenue trends and margin commentary. DENTSPLY SIRONA (XRAY) Expected to Announce Earnings on Thursday
• Neutral Sentiment: Short-interest data reported in the last two days shows anomalous figures (zeros/NaN), suggesting a reporting error rather than a true surge in shorting; this makes short-interest-driven moves unlikely unless corrected data emerges.
• Negative Sentiment: A Zacks preview warns that XRAY lacks the setup for an earnings beat in the coming report, which could cap upside and lead to a pullback if results or guidance disappoint. Traders should weigh the upgrade optimism against this caution. Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release

Wall Street Analysts Forecast Growth

Several research analysts have commented on XRAY shares. Stifel Nicolaus set a $13.00 price target on DENTSPLY SIRONA in a research report on Thursday, November 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, January 21st. JPMorgan Chase & Co. decreased their price target on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Mizuho lifted their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Tuesday, January 20th. Finally, Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Tuesday, December 16th. Three equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $14.46.

DENTSPLY SIRONA Stock Up 0.2%

XRAY stock opened at $12.54 on Friday. The stock has a market capitalization of $2.50 billion, a PE ratio of -2.84, a price-to-earnings-growth ratio of 0.98 and a beta of 1.01. The company has a fifty day moving average of $12.23 and a 200-day moving average of $12.49. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47. DENTSPLY SIRONA Inc. has a one year low of $9.85 and a one year high of $19.27.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were given a $0.16 dividend. The ex-dividend date was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.1%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.48%.

Insiders Place Their Bets

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.50% of the company’s stock.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.